XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options - SARs (Details) - USD ($)
3 Months Ended
Apr. 18, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
SARs        
Outstanding beginning balance   465,250    
Forfeited   (10,000)    
Outstanding ending balance   455,250    
Weighted average exercise price        
Weighted average exercise price, beginning balance (per share)   $ 39.35    
Weighted average exercise price, forfeited (per share)   39.33    
Weighted average exercise price, ending balance (per share)   $ 39.35    
Aggregate intrinsic value        
Aggregate intrinsic value   $ 7,643,000    
Weighted average remaining contractual term (years)   8 years 3 months    
Stock Appreciation Rights (SARs)        
Aggregate intrinsic value        
Fair Value of Liability   $ 2,544,000   $ 1,464,000
Stock-based compensation expense   1,080,000 $ 166,000  
Stock-based compensation cost, unrecognized   $ 7,572,000    
Stock-based compensation cost, unrecognized, weighted-average period of recognition   8 years 3 months 18 days    
Stock Appreciation Rights (SARs) | SAR Plan        
Stock option details        
Shares available for future grants 750,000      
Maximum exercisable period for granted share-based compensation 10 years      
Number of rights issued   455,250    
Vesting period 8 years      
SARs        
Granted   455,250